Quintiles Transitional Holdings Inc. (NYSE:Q) had its price objective upped by equities researchers at Jefferies Group LLC from $107.00 to $110.00 in a report issued on Monday. The brokerage presently has a “hold” rating on the medical research company’s stock. Jefferies Group LLC’s target price indicates a potential upside of 1.76% from the company’s current price.

Other equities research analysts also recently issued research reports about the stock. Barclays PLC restated an “overweight” rating and issued a $98.00 price objective (up previously from $90.00) on shares of Quintiles Transitional Holdings in a research report on Monday, July 17th. Stifel Nicolaus upgraded shares of Quintiles Transitional Holdings from a “hold” rating to a “buy” rating and raised their price objective for the company from $92.00 to $128.00 in a research report on Friday, October 27th. William Blair upgraded shares of Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and raised their price objective for the company from $70.10 to $93.42 in a research report on Friday, August 4th. Royal Bank Of Canada began coverage on shares of Quintiles Transitional Holdings in a research report on Tuesday, September 19th. They issued an “outperform” rating and a $116.00 price objective for the company. Finally, Citigroup Inc. raised their price objective on shares of Quintiles Transitional Holdings from $96.00 to $97.00 and gave the company a “neutral” rating in a research report on Monday, August 7th. Eight equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. Quintiles Transitional Holdings presently has a consensus rating of “Buy” and a consensus target price of $101.64.

Quintiles Transitional Holdings (NYSE Q) opened at 108.10 on Monday. Quintiles Transitional Holdings has a 1-year low of $70.10 and a 1-year high of $108.81. The firm’s 50 day moving average price is $98.22 and its 200-day moving average price is $91.01. The stock has a market cap of $23.41 billion, a price-to-earnings ratio of 313.33 and a beta of 0.62.

Quintiles Transitional Holdings (NYSE:Q) last announced its earnings results on Thursday, October 26th. The medical research company reported $1.19 earnings per share for the quarter, topping the consensus estimate of $1.14 by $0.05. Quintiles Transitional Holdings had a net margin of 0.58% and a return on equity of 12.60%. The business had revenue of $2.02 billion during the quarter, compared to the consensus estimate of $2.01 billion. During the same quarter in the prior year, the firm earned $1.00 earnings per share. The business’s quarterly revenue was up 77.6% compared to the same quarter last year. On average, equities analysts anticipate that Quintiles Transitional Holdings will post $4.61 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Jefferies Group LLC Increases Quintiles Transitional Holdings Inc. (Q) Price Target to $110.00” was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece of content on another publication, it was stolen and republished in violation of United States & international trademark & copyright legislation. The legal version of this piece of content can be read at https://theolympiareport.com/2017/11/01/jefferies-group-llc-increases-quintiles-transitional-holdings-inc-q-price-target-to-110-00.html.

In other news, insider James H. Erlinger III sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 18th. The shares were sold at an average price of $100.51, for a total transaction of $1,005,100.00. Following the completion of the transaction, the insider now directly owns 27,340 shares of the company’s stock, valued at approximately $2,747,943.40. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Kevin C. Knightly sold 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 9th. The stock was sold at an average price of $90.28, for a total transaction of $1,805,600.00. Following the transaction, the insider now directly owns 46,826 shares of the company’s stock, valued at $4,227,451.28. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 14,208,382 shares of company stock valued at $1,362,839,475. 6.40% of the stock is currently owned by corporate insiders.

Several institutional investors and hedge funds have recently modified their holdings of Q. Janus Henderson Group PLC increased its stake in shares of Quintiles Transitional Holdings by 33,092.0% during the 2nd quarter. Janus Henderson Group PLC now owns 6,531,857 shares of the medical research company’s stock worth $584,601,000 after purchasing an additional 6,512,178 shares in the last quarter. Glenview Capital Management LLC increased its stake in shares of Quintiles Transitional Holdings by 29.3% during the 2nd quarter. Glenview Capital Management LLC now owns 8,921,356 shares of the medical research company’s stock worth $798,461,000 after purchasing an additional 2,023,719 shares in the last quarter. Royal Bank of Canada increased its stake in shares of Quintiles Transitional Holdings by 103.8% during the 2nd quarter. Royal Bank of Canada now owns 59,335 shares of the medical research company’s stock worth $5,310,000 after purchasing an additional 1,601,888 shares in the last quarter. Discovery Capital Management LLC CT purchased a new position in shares of Quintiles Transitional Holdings during the 2nd quarter worth approximately $95,228,000. Finally, Laurion Capital Management LP purchased a new position in shares of Quintiles Transitional Holdings during the 2nd quarter worth approximately $54,510,000. 93.03% of the stock is owned by institutional investors and hedge funds.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Analyst Recommendations for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.